TITLE

Diuretic-based therapy reduced cardiovascular mortality in older patients with isolated systolic hypertension and diabetes

PUB. DATE
May 2005
SOURCE
ACP Journal Club;May/Jun2005, Vol. 142 Issue 3, p64
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that diuretic-based therapy reduced cardiovascular mortality in older patients with isolated systolic hypertension and diabetes. The study focuses on the long-term effectiveness of a diuretic-based, stepped-care antihypertensive therapy compared with placebo in older patients with isolated systolic hypertension (ISH) with or without diabetes. It was found that patients who had diabetes at baseline or who developed diabetes during follow-up and received stepped care had lower mortality rates than did those who received placebo.
ACCESSION #
17116523

 

Related Articles

  • Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus. Gami, Apoor S.; Smith, Steven A. // Evidence Based Medicine;Apr2005, Vol. 10 Issue 2, p43 

    The article cites a research study, which reported that atorvastatin reduced malor cardiovascular disease events in type 2 diabetes mellitus. The researchers concluded that in patients with type 2 diabetes mellitus, atorvastatin reduced major cardiovascular disease events. It reported that The...

  • Management of diabetes in cardiovascular patients. Peter, R.; Cox, A.; Evans, M. // Heart;Mar2008, Vol. 94 Issue 3, p369 

    The article presents information on diabetes management to the patients with cardiovascular disease. Accordingly, the type 2 diabetes mellitus (T2DM) is one of the major health problems worldwide and mentions that cardiovascular diseases are the most significant causes of death of patients with...

  • Comment on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116-2121. Sho-ichi Yamagishi // Diabetes;Oct2013, Vol. 62 Issue 10, pe26 

    A letter the editor is presented in response to the article "sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death," by E. Selvin et al. in the 2013 issue of "Diabetes."

  • Response to Comments on: Selvin et al. sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death. Diabetes 2013;62:2116-2121. Selvin, Elizabeth; Coresh, Josef; Halushka, Marc K. // Diabetes;Oct2013, Vol. 62 Issue 10, pe27 

    A response by Elizabeth Selvin, Josef Coresh and Marc K. Halushka to a letter the editor about their article "sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death," in the 2013 issue of "Diabetes" is presented.

  • Oral sulfonylureas and CV mortality. Aronow, Wilbert S. // Geriatrics;Sep2004, Vol. 59 Issue 9, p45 

    Oral sulfonylureas, particularly the cost-effective first generation agents, are a mainstay of treatment for patients with type 2 diabetes mellitus. The University Group Diabetes Program (UGDP) found that sulfonylureas increased cardiovascular (CV) mortality in patients with diabetes mellitus....

  • Ambulatory ECG-based T-wave alternans and heart rate turbulence can predict cardiac mortality in patients with myocardial infarction with or without diabetes mellitus. Ren Li-na; Fang Xin-hui; Ren Li-dong; Gong Jian; Wang Yong-quan; Qi Guo-xian // Cardiovascular Diabetology;2012, Vol. 11 Issue 1, p104 

    Background: Many patients who survive a myocardial infarction (MI) remain at risk of sudden cardiac death despite revascularization and optimal medical treatment. We used the modified moving average (MMA) method to assess the utility of T-wave alternans (TWA) and heart rate turbulence (HRT) as...

  • Reducing cardiovascular risk in patients with diabetes. Pasternak, Richard; Snow, Vincenza; Hines, Silvia E. // Patient Care;Sep2003, Vol. 37 Issue 9, p20 

    Urges physicians to adopt evidence-based strategies to lessen the risk of cardiovascular morbidity and mortality in patients with diabetes. Recognition of the principal cardiovascular risk factors; Preventive treatment; Evidence-based guidelines for blood pressure control; Treatment of diabetes...

  • Transcriptional Control of Apolipoprotein A-1 Gene Expression in Diabetes. Mooradian, Arshag D.; Haas, Michael J.; Wong, Norman C. W. // Diabetes;Mar2004, Vol. 53 Issue 3, p513 

    Cardiovascular disease continues to be the leading cause of mortality in diabetes. One of the factors contributing to the increased risk is the high prevalence rate of low plasma concentrations of HDL cholesterol. Multiple potential mechanisms account for the cardioprotective effects of HDL and...

  • Risk of Cardiovascular and All-Cause Mortality: Impact of Impaired Health-Related Functioning and Diabetes. Williams, Emily D.; Rawal, Lal; Oldenburg, Brian F.; Renwick, Carla; Shaw, Jonathan E.; Tapp, Robyn J. // Diabetes Care;May2012, Vol. 35 Issue 5, p1067 

    OBJECTIVE--There is an established link between health-related functioning (HRF) and cardiovascular disease (CVD) mortality, and it is known that those with diabetes predominantly die of CVD. However, few studies have determined the combined impact of diabetes and impaired HRF on CVD mortality....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics